(Q41440255)

30 September 2017

1 reference

title

Clinically significant drug interactions with new immunosuppressive agents (English)

1 reference

30 September 2017

C Mignat

1

1 reference

30 September 2017

1 April 1997

1 reference

30 September 2017

1 reference

30 September 2017

16

1 reference

30 September 2017

4

1 reference

30 September 2017

267-278

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199716040-00004

30 September 2017

0 references

cites work

FK 506 inhibition of cyclosporine metabolism by human liver microsomes

1 reference

12 December 2020

Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients

1 reference

12 December 2020

The design and development of an immunosuppressive drug, mycophenolate mofetil

1 reference

12 December 2020

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

12 December 2020

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

12 December 2020

Torsades de pointes associated with astemizole (Hismanal) therapy

1 reference

12 December 2020

Pulse therapy for rejection with deoxyspergualin in renal recipients: a multicenter controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Paranoid psychosis with indomethacin

1 reference

12 December 2020

Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression

1 reference

12 December 2020

Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506

1 reference

12 December 2020

Interaction between FK506 and clotrimazole in a liver transplant recipient

1 reference

12 December 2020

Interaction between FK 506 and clarithromycin in a renal transplant patient

1 reference

12 December 2020

Interaction between tacrolimus and erythromycin

1 reference

12 December 2020

FK 506 interaction with danazol

1 reference

12 December 2020

The question of FK 506 nephrotoxicity after liver transplantation

1 reference

12 December 2020

Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506.

1 reference

12 December 2020

Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.

1 reference

12 December 2020

Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man

1 reference

12 December 2020

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

1 reference

12 December 2020

An extended study of indomethacin. I. Clinical pharmacology

1 reference

12 December 2020

Clinical pharmacokinetics of tacrolimus

1 reference

12 December 2020

FK 506/fluconazole interaction enhances FK 506 nephrotoxicity

1 reference

12 December 2020

In-vitro interaction of a novel immunosuppressant, FK 506, and antacids

1 reference

12 December 2020

OKT3 treatment of steroid-resistant renal allograft rejection.

1 reference

12 December 2020

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

12 December 2020

Pharmacokinetics of oral mycophenolate mofetil in volunteer subjects with varying degrees of hepatic oxidative impairment

1 reference

12 December 2020

Interactions of FK 506 and cyclosporine metabolism

1 reference

12 December 2020

Clinically significant drug interactions with cyclosporin. An update

1 reference

12 December 2020

Mechanisms of action of new immunosuppressive drugs.

1 reference

12 December 2020

Grapefruit juice and drugs. How significant is the interaction?

1 reference

12 December 2020

Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia

1 reference

12 December 2020

Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes

1 reference

12 December 2020

Encephalopathy associated with OKT3 administration. Possible interaction with indomethacin.

1 reference

12 December 2020

Paranoid psychosis with indomethacin

1 reference

12 December 2020

Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes

1 reference

12 December 2020

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

12 December 2020

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

1 reference

12 December 2020

Interactions of FK506 (tacrolimus) with clinically important drugs

1 reference

12 December 2020

FK 506 for liver, kidney, and pancreas transplantation

1 reference

12 December 2020

Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat

1 reference

12 December 2020

Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin.

1 reference

12 December 2020

Interaction between FK506 and erythromycin

1 reference

12 December 2020

Fluconazole therapy in transplant recipients receiving FK506.

1 reference

12 December 2020

The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506.

1 reference

12 December 2020

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

12 December 2020

Prevention and management of the adverse effects associated with immunosuppressive therapy

1 reference

12 December 2020

Muromonab CD3. A review of its pharmacology and therapeutic potential

1 reference

12 December 2020

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

1 reference

12 December 2020

10.2165/00002018-199716040-00004

Identifiers

DOI

1 reference

PubMed ID

9113494

Dimensions Publication ID

30 September 2017

0 references

1 reference

PubMed ID

9113494